Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,980,249
-
Share change
-
-81,186
-
Total reported value
-
$26,657,365
-
Put/Call ratio
-
44%
-
Price per share
-
$2.67
-
Number of holders
-
63
-
Value change
-
-$295,234
-
Number of buys
-
15
-
Number of sells
-
30
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q3 2020
As of 30 Sep 2020,
GALECTIN THERAPEUTICS INC - COM NEW (GALT) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,980,249 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ADVISOR GROUP HOLDINGS, INC., D.A. DAVIDSON & CO., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Cambridge Investment Research Advisors, Inc., Cutter & CO Brokerage, Inc., and Nuveen Asset Management, LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.